Named Bioactive Compounds · Compound
Diosgenin (Steroidal Saponin)
Moderate Evidencesaponin
Hermetica Superfood Encyclopedia
Diosgenin is a steroidal saponin extracted from wild yam and fenugreek that serves as a precursor to various steroid hormones. It modulates estrogen receptors and enhances cognitive function through neurosteroid synthesis pathways.
Diosgenin is a naturally occurring steroidal saponin compound found primarily in plants of the Dioscorea (yam) genus and Trigonella foenum-graecum (fenugreek). It is extracted from plant sources through solvent-based methods targeting the saponin-rich fractions of these plants.
Clinical evidence for diosgenin remains limited, with only a few human trials completed. The most notable include a cognitive enhancement study using diosgenin-rich yam extract and a pilot study (n=143) evaluating a combination formula for erectile dysfunction that showed significant improvement. However, a bioavailability study administering 3 g/day orally for 4 weeks failed to produce detectable serum levels, highlighting absorption challenges.
Clinically studied dosages vary by application: Cognitive enhancement used diosgenin-rich yam extract (dose unspecified); erectile dysfunction trial used a combination formula administered on alternate days for 3 months; animal studies typically use 5-100 mg/kg/day. No standardized human dosage has been established due to limited clinical trials and poor oral bioavailability. Consult a healthcare provider before starting any new supplement.
Diosgenin is a steroidal sapogenin (aglycone of dioscin) with the molecular formula C₂₇H₄₂O₃ (MW 414.63 g/mol). It is not a nutritional macronutrient source but rather a bioactive phytochemical. Key profile details: • Chemical class: Spirostanol-type steroidal sapogenin derived from furostanol and spirostanol saponin glycosides (primarily dioscin, protodioscin, and gracillin). • Natural concentrations: Found in Dioscorea species (wild yam) tubers at approximately 1–6% dry weight depending on species (D. villosa, D. opposita, D. zingiberensis, D. nipponica); fenugreek (Trigonella foenum-graecum) seeds contain ~0.1–0.8% diosgenin; also present in lesser amounts in Costus speciosus rhizomes and Paris polyphylla. • Standardized extract concentrations: Commercial diosgenin-rich yam extracts are typically standardized to 10–20% diosgenin content; some pharmaceutical-grade isolates reach ≥95% purity. • Bioactive structural features: Contains a spiroketal side chain (rings E and F), 3β-hydroxyl group on ring A, and Δ⁵-unsaturation — structural features responsible for its interaction with steroid hormone receptors, anti-inflammatory pathways (NF-κB inhibition, COX-2 suppression), and amyloid-β reduction mechanisms. • No significant macronutrient value (negligible calories, protein, fat, carbohydrate contribution at therapeutic doses of ~50–200 mg/day). • No appreciable vitamin or mineral content as an isolated compound. • Bioavailability notes: Oral bioavailability of free diosgenin is relatively low due to poor aqueous solubility (log P ~4.8, practically insoluble in water); absorption is improved when consumed with dietary lipids or formulated with cyclodextrins or nanoparticle carriers. Glycosylated precursors (dioscin, protodioscin) undergo hydrolysis by gut microbiota β-glucosidases to release free diosgenin in the colon, which is then absorbed. Reported oral bioavailability in animal models is approximately 4–7% for unformulated diosgenin. Hepatic first-pass metabolism involves CYP3A4-mediated oxidation. Peak plasma concentrations after oral dosing (in rodent models) occur at approximately 1–4 hours. • Associated co-occurring bioactives in whole-food sources: Dioscorea tubers also provide dietary fiber (~1.5–2.5 g/100g fresh weight), potassium (~500–800 mg/100g), vitamin C (~12–17 mg/100g), manganese, copper, B-vitamins (B₁, B₆), and allantoin; fenugreek seeds additionally supply galactomannan fiber, 4-hydroxyisoleucine, and trigonelline.
Diosgenin acts as a precursor to pregnenolone and DHEA, facilitating neurosteroid synthesis in brain tissue. It modulates estrogen receptor beta (ERβ) activity and influences the hypothalamic-pituitary-gonadal axis. The compound also enhances acetylcholine synthesis and supports nitric oxide production through endothelial function.
A randomized, double-blind crossover study demonstrated that diosgenin-rich yam extract improved cognitive performance in healthy adults with moderate evidence quality. A clinical pilot study with 143 participants showed significant improvement in erectile function parameters. However, most research remains preliminary with limited long-term safety data and optimal dosing protocols still under investigation.
Diosgenin is generally well-tolerated at typical supplemental doses of 100-400mg daily. It may interact with hormone replacement therapy and anticoagulant medications due to its steroid precursor activity. Pregnant and breastfeeding women should avoid diosgenin supplements as safety data is insufficient. Minor gastrointestinal upset and headaches have been reported in some users.
